共 50 条
- [1] ALECTINIB IS ACTIVE IN CRIZOTINIB-RESISTANT ALK-REARRANGED NSCLC [J]. CANCER DISCOVERY, 2014, 4 (10) : 1113 - 1113
- [2] Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung [J]. SURGICAL CASE REPORTS, 2018, 4